Abstract
The increasing use of immune checkpoint inhibitors in clinical practice is associated with a broad spectrum of immune-related adverse events, such as cardiac, rheumatological and neurological toxicities. Myocarditis is a...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have